• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗甲癣的新型全身性抗真菌药物。

Newer systemic antifungal drugs for the treatment of onychomycosis.

作者信息

Chiritescu M M, Chiritescu M E, Scher R K

机构信息

Department of Medicine, New York Hospital Medical Center of Queens, USA.

出版信息

Clin Podiatr Med Surg. 1996 Oct;13(4):741-58.

PMID:8902341
Abstract

Onychomycosis, the infection of the nail unit by any fungus, far from being just a cosmetic problem, has significant psychological, physical, social, and financial implications. Further, it has experienced a dramatic rise in incidence in recent years. The introduction of newer systemic antifungal drugs (itraconazole, fluconazole, and terbinafine) offer an increased cure rate, a broader spectrum of activity, shortening of the treatment period, and increased safety, compared with the traditional systemic antifungal drugs griseofulvin and ketoconazole. Because the fungi involved are difficult to eradicate from the floors of communal bathing facilities, where the infection is often contracted, an effective treatment is likely to have a significant impact on disease prevalence.

摘要

甲癣,即任何真菌对指甲单元的感染,远非只是一个美容问题,它还具有重大的心理、身体、社会和经济影响。此外,近年来其发病率急剧上升。与传统的全身性抗真菌药物灰黄霉素和酮康唑相比,新型全身性抗真菌药物(伊曲康唑、氟康唑和特比萘芬)的引入提高了治愈率,扩大了活性谱,缩短了治疗周期,并提高了安全性。由于感染往往在公共浴室地面发生,而此处涉及的真菌难以根除,有效的治疗可能会对疾病流行率产生重大影响。

相似文献

1
Newer systemic antifungal drugs for the treatment of onychomycosis.用于治疗甲癣的新型全身性抗真菌药物。
Clin Podiatr Med Surg. 1996 Oct;13(4):741-58.
2
The systemic treatment of onychomycosis.甲癣的全身治疗
Clin Podiatr Med Surg. 2004 Oct;21(4):579-89, vi. doi: 10.1016/j.cpm.2004.05.003.
3
Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.系统性抗真菌药物治疗甲癣的累积荟萃分析。
Br J Dermatol. 2004 Mar;150(3):537-44. doi: 10.1046/j.1365-2133.2003.05728.x.
4
The systemic treatment of onychomycosis.甲癣的全身治疗
Clin Podiatr Med Surg. 1995 Apr;12(2):263-74.
5
Current trends in onychomycosis therapy: a literature review.甲癣治疗的当前趋势:文献综述
Mt Sinai J Med. 1997 Nov;64(6):399-405.
6
Oral therapeutic agents in fungal nail disease.用于治疗甲真菌病的口服治疗药物。
J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S78-81. doi: 10.1016/s0190-9622(08)81274-1.
7
Successful treatment of proximal white subungual onychomycosis with oral terbinafine therapy.口服特比萘芬治疗近端白色甲下甲真菌病取得成功。
J Coll Physicians Surg Pak. 2008 Nov;18(11):728-9.
8
The use of oral antifungal agents to treat onychomycosis.口服抗真菌药物用于治疗甲癣。
Dermatol Clin. 2003 Jul;21(3):469-79, vi. doi: 10.1016/s0733-8635(03)00027-5.
9
The new oral antifungal agents for onychomycosis of the toenails.用于治疗趾甲甲真菌病的新型口服抗真菌药物。
J Eur Acad Dermatol Venereol. 1999 Jul;13(1):1-13.
10
Management of onychomycosis in children.儿童甲癣的治疗
Postgrad Med. 1999 Jul;Spec No:31-7.

引用本文的文献

1
Common fungal infections of the feet in patients with diabetes mellitus.糖尿病患者足部常见的真菌感染
Drugs Aging. 2004;21(2):101-12. doi: 10.2165/00002512-200421020-00003.
2
Pharmacokinetics of antifungal agents in onychomycoses.抗真菌药物在甲癣中的药代动力学。
Clin Pharmacokinet. 2001;40(6):441-72. doi: 10.2165/00003088-200140060-00005.
3
An overview of fungal infections.真菌感染概述。
Drugs. 2001;61 Suppl 1:1-12. doi: 10.2165/00003495-200161001-00001.
4
A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.用于治疗甲癣的新型口服抗真菌药物的风险效益评估。
Drug Saf. 2000 Jan;22(1):33-52. doi: 10.2165/00002018-200022010-00004.